Enzyme-linked immunosorbent assay for detection of Plasmodium falciparum histidine-rich protein 2 in blood, plasma, and serum

Clinical and Vaccine Immunology

Volumn 15, Issue 6, 2008, Pages 1012-1018

  Kifude, Carolyne M ^a   Rajasekariah, Halli G ^b   Sullivan Jr , David J ^c   Stewart, V Ann ^a   Angov, Evelina ^d   Martin, Samuel K ^a   Diggs, Carter L ^e   Waitumbi, John N ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Mahidol University   (Thailand)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE RICH PROTEIN 2; PROTOZOAL PROTEIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; HUMAN CELL; MICROSCOPY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTEINS; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS;

EID: 47049127565     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00385-07     Document Type: Article

References (30)

1. Amexo, M., R. Tolhurst, G. Barnish, and I. Bates. 2004. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 364:1896-1898.
2. Bacon, D. J., C. Latour, C. Lucas, O. Colina, P. Ringwald, and S. Picot. 2007. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob. Agents Chemother. 51:1172-1178.
3. Baker, J., J. McCarthy, M. Gatton, D. E. Kyle, V. Belizario, J. Luchavez, D. Bell, and Q. Cheng. 2005. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J. Infect. Dis. 192:870-877.
4. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
5. Chiodini, P. L., K. Bowers, P. Jorgensen, J. W. Barnwell, K. K. Grady, J. Luchavez, A. H. Moody, A. Cenizal, and D. Bell. 2007. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans. R. Soc. Trop. Med. Hyg. 101:331-337.
6. Desakorn, V., A. M. Dondorp, K. Silamut, W. Pongtavornpinyo, D. Sahassananda, K. Chotivanich, P. Pitisuttithum, A. M. Smithyman, N. P. J. Day, and N. J. White. 2005. Stage-dependent production and release of histidinerich protein 2 by Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 99:517-524.
7. Desakorn, V., K. Silamut, B. Angus, D. Sahassananda, K. Chotivanich, P. Suntharasamai, J. Simpson, and N. J. White. 1997. Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma. Trans. R. Soc. Trop. Med. Hyg. 91:479-483.
8. Doderer, C., A. Heschung, P. Guntz, J.-P. Cazenave, Y. Hansmann, A. Senegas, A. W. Pfaff, T. Abdelrahman, and E. Candolfi. 2007. A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies. Malar. J. 6:19.
9. Dondorp, A. M., V. Desakorn, W. Pongtavornpinyo, D. Sahassananda, K. Silamut, K. Chotivanich, P. N. Newton, P. Pitisuttithum, A. M. Smithyman, N. J. White, and N. P. J. Day. 2005. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2:e204. (Erratum, 2:390.)
10. Hänscheid, T. 2003. Current strategies to avoid misdiagnosis of malaria. Clin. Microbiol. Infect. 9:497-504.
11. Hopkins, H., W. Kambale, M. R. Kamya, S. G. Staedke, G. Dorsey, and P. J. Rosenthal. 2007. Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda. Am. J. Trop. Med. Hyg. 76:1092-1097.
12. Howard, R. J., S. Uni, M. Aikawa, S. B. Aley, J. H. Leech, A. M. Lew, T. E. Wellems, J. Rener, and D. W. Taylor. 1986. Secretion of a malarial histidinerich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J. Cell Biol. 103:1269-1277.
13. Iqbal, J., N. Khalid, and P. R. Hira. 2002. Comparison of two commercial assays with expert microscopy for confirmation of symptomatically diagnosed malaria. J. Clin. Microbiol. 40:4675-4678.
14. Kiser, M. M., and J. W. Dolan. 2004. Selecting the best curve fit. LCGC Europe 17:138-143.
15. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
16. Leke, R. F., R. R. Djokam, R. Mbu, R. J. Leke, J. Fogako, R. Megnekou, S. Metenou, G. Sama, Y. Zhou, T. Cadigan, M. Parra, and D. W. Taylor. 1999. Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria. J. Clin. Microbiol. 37:2992-2996.
17. Mayxay, M., S. Pukrittayakamee, K. Chotivanich, S. Looareesuwan, and N. J. White. 2001. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 95:179-182.
18. McKenzie, F. E., J. Sirichaisinthop, R. S. Miller, R. A. Gasser, Jr., and C. Wongsrichanalai. 2003. Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am. J. Trop. Med. Hyg. 69:372-376.
19. Moody, A. 2002. Rapid diagnostic tests for malaria parasites. Clin. Microbiol. Rev. 15:66-78.
20. Noedl, H., W. H. Wernsdorfer, R. S. Miller, and C. Wongsrichanalai. 2002. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob. Agents Chemother. 46:1658-1664.
21. Ohrt, C., P. Obare, A. Nanakorn, C. Adhiambo, K. Awuondo, W. P. O'Meara, S. Remich, K. Martin, E. Cook, J.-P. Chretien, C. Lucas, J. Osoga, P. McEvoy, M. L. Owaga, J. S. Odera, and B. Ogutu. 2007. Establishing a malaria diagnostics centre of excellence in Kisumu, Kenya. Malar. J. 6:79.
22. Ohrt, C., Purnomo, M. A. Sutamihardja, D. Tang, and K. C. Kain. 2002. Impact of microscopy error on estimates of protective efficacy in malariaprevention trials. J. Infect. Dis. 186:540-546.
23. Parra, M. E., C. B. Evans, and D. W. Taylor. 1991. Identification of Plasmodium falciparum histidine-rich protein 2 in the plasma of humans with malaria. J. Clin. Microbiol. 29:1629-1634.
24. Piper, R., J. Lebras, L. Wentworth, A. Hunt-Cooke, S. Houze, P. Chiodini, and M. Makler. 1999. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am. J. Trop. Med. Hyg. 60:109-118.
25. Rock, E. P., K. Marsh, A. J. Saul, T. E. Wellems, D. W. Taylor, W. L. Maloy, and R. J. Howard. 1987. Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology 95:209-227.
26. Taylor, D. W., and A. Voller. 1993. The development and validation of a simple antigen detection ELISA for Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 87:29-31.
27. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
28. USDHHS, FDA Center for Drug Evaluation and Research. 2001. Guidance for industry: bioanalytical method validation. Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD. http://www.fda.gov/cder/guidance/index.htm.
29. Voller, A., D. E. Bidwell, and P. L. Chiodini. 1994. Evaluation of a malaria antigen ELISA. Trans R Soc Trop. Med. Hyg. 88:188.
30. Wellems, T. E., E. P. Rock, W. L. Maloy, D. W. Taylor, and R. J. Howard. 1986. Histidine-rich proteins in Plasmodium falciparum: an update and perspective. UCLA Symp. Mol. Cell. Biol. 42:47-58.